David Hyman
E561042
David Hyman is an oncologist and biopharmaceutical executive known for his leadership in precision cancer medicine and his role in building innovative oncology drug development programs.
All labels observed (1)
| Label | Occurrences |
|---|---|
| David Hyman canonical | 1 |
Statements (26)
| Predicate | Object |
|---|---|
| instanceOf |
biopharmaceutical executive
ⓘ
oncologist ⓘ person ⓘ |
| contributedTo |
advancement of precision oncology drug development
ⓘ
design of innovative oncology clinical trials ⓘ |
| fieldOfWork |
cancer drug development
ⓘ
clinical trials ⓘ oncology ⓘ precision oncology ⓘ |
| focusesOn |
developing targeted therapies for cancer
ⓘ
innovative oncology drug development ⓘ precision medicine strategies in oncology ⓘ |
| hasExpertise |
early-phase oncology clinical trials
ⓘ
molecularly targeted agents ⓘ oncology translational research ⓘ precision medicine clinical development ⓘ targeted cancer therapies ⓘ |
| knownFor |
building innovative oncology drug development programs
ⓘ
leadership in precision cancer medicine ⓘ |
| notableRole | leader in precision cancer medicine ⓘ |
| occupation |
biotech executive
ⓘ
medical oncologist ⓘ |
| specialty |
medical oncology
ⓘ
precision cancer medicine ⓘ |
| worksOn |
cancer clinical development programs
ⓘ
precision oncology trials ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.
subject surface form:
Loxo Oncology